永安药业(002365.SZ)：前三季度净利润2549.63万元 同比减少58.78%

Core Viewpoint - Yong'an Pharmaceutical (002365.SZ) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating income of 577 million yuan, representing a year-on-year decrease of 6.72% [1] - The net profit attributable to shareholders was 25.5 million yuan, down 58.78% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 5.18 million yuan, a decrease of 86.17% year-on-year [1] - Basic earnings per share were reported at 0.0881 yuan [1]